SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Shandong Boan Signs Japan Denosumab Licensing Deal

Shandong Boan Biotechnology signed a licensing deal for denosumab in Japan.

Related stories